
Drug company settles fraud allegations for $3B
July 2, 2012 4:13 PM
GlaxoSmithKline will pay $3 billion in penalties to settle a long list of allegations including criminal charges claiming it illegally marketed two of its biggest sellers - antidepressant drugs Paxil and Wellbutrin. Bob Orr reports.














